These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2593826)

  • 1. Control of mycoplasma contamination in hybridoma technology.
    Bongertz V; Thomaz N
    Mem Inst Oswaldo Cruz; 1988; 83(2):265-6. PubMed ID: 2593826
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycoplasma contamination: a hazard of screening hybridoma supernatants for inhibition of [3H]thymidine incorporation.
    Jakway JP; Shevach EM
    J Immunol Methods; 1984 Mar; 67(2):337-45. PubMed ID: 6608555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of mycoplasma, bacteria, and fungi contaminants of hybridoma cultures by intraperitoneal passage in the mouse.
    Roseto A; Guillemin MC; Chehimi J; Mazeron MC; Périès J
    Hybridoma; 1984; 3(3):297-300. PubMed ID: 6500586
    [No Abstract]   [Full Text] [Related]  

  • 4. The elimination of mycoplasma from infected hybridomas by passaging in BALB/c mice.
    Carroll K; O'Kennedy R
    J Immunol Methods; 1988 Apr; 108(1-2):189-93. PubMed ID: 2450926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of mycoplasmas from mouse myeloma cells by intraperitoneal passage in mice and by antibiotic treatment.
    Hirschberg L; Bölske G; Holme T
    Hybridoma; 1989 Apr; 8(2):249-57. PubMed ID: 2714817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of three methods for curing hybridomas from mycoplasma contamination.
    Ravaoarinoro M; Lecomte J
    Hybridoma; 1988 Feb; 7(1):79-86. PubMed ID: 2453449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants of an interspecies hybridoma with altered tumorigenicity and protective ability against mouse myeloma tumors.
    Baumal R; Musclow E; Farkas-Himsley H; Marks A
    Cancer Res; 1982 May; 42(5):1904-8. PubMed ID: 7066902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mycoplasma infection as a possible cause of hybridoma instability].
    Volgareva GM; Neustroeva VV; Sviridov VV
    Mol Gen Mikrobiol Virusol; 1985 Jan; (1):34-8. PubMed ID: 3879880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression of reverse transcriptase activity by hybridoma supernatants: a potential problem in screening for retroviral contamination.
    Lyon M; Huppert J
    Biochem Biophys Res Commun; 1983 Apr; 112(1):265-72. PubMed ID: 6188467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternative method for the isolation of NS-1 hybridomas using cholesterol auxotrophy of NS-1 mouse myeloma cells.
    Myoken Y; Okamoto T; Osaki T; Yabumoto M; Sato GH; Takada K; Sato JD
    In Vitro Cell Dev Biol; 1989 May; 25(5):477-80. PubMed ID: 2732203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a mycoplasma elimination reagent on a mycoplasma-contaminated hybridoma cell line.
    Kumar A; Ali A; Yerneni LK
    Hybridoma (Larchmt); 2007 Apr; 26(2):104-6. PubMed ID: 17451359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of flow cytometry in hybridoma technology].
    Khristov K; Bratanov M
    Eksp Med Morfol; 1988; 27(3):1-6. PubMed ID: 3220039
    [No Abstract]   [Full Text] [Related]  

  • 13. Ridding Hybridoma Cells of
    Greenfield EA
    Cold Spring Harb Protoc; 2021 Jul; 2021(7):. PubMed ID: 34210773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies against tumour-associated antigens: mycoplasma as a major technical obstacle and its possible circumvention by azaserine selection medium.
    Karsten U; Rudolph M
    Arch Geschwulstforsch; 1985; 55(5):305-10. PubMed ID: 4062491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A "lymphokine-like" soluble product that induces proliferation and maturation of B cells appears in the serum-free supernatant of a T cell hybridoma as a consequence of mycoplasmal contamination.
    Proust JJ; Buchholz MA; Nordin AA
    J Immunol; 1985 Jan; 134(1):390-6. PubMed ID: 3871110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curing human hybridomas infected with Mycoplasma hyorhinis.
    Borup-Christensen P; Erb K; Jensenius JC
    J Immunol Methods; 1988 Jun; 110(2):237-40. PubMed ID: 3379313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfection of NS0 myeloma fusion partner cells with HSP70 gene results in higher hybridoma yield by improving cellular resistance to apoptosis.
    Lasunskaia EB; Fridlianskaia II; Darieva ZA; da Silva MS; Kanashiro MM; Margulis BA
    Biotechnol Bioeng; 2003 Feb; 81(4):496-504. PubMed ID: 12491534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing Hybridoma Cells for
    Greenfield EA
    Cold Spring Harb Protoc; 2021 Jul; 2021(7):. PubMed ID: 34210772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bioassay for Optimization of Macrophage-Conditioned Medium as a Culture Supplement to Promote Hybridoma Cell Survival and Growth.
    Hnasko R; Lin AV; Stanker L; McGarvey J
    Monoclon Antib Immunodiagn Immunother; 2018 Jun; 37(3):126-133. PubMed ID: 29901420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning of human hybridoma, myeloma and lymphoma cell lines using enriched human monocytes as feeder layer.
    Brodin T; Olsson L; Sjögren HO
    J Immunol Methods; 1983 May; 60(1-2):1-7. PubMed ID: 6343495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.